Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEPHEN J SCHUSTER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1033147566
CMS profile
138084
Location
PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$49,340.48

53 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $25,301.50 6
Travel and Lodging $21,732.31 10
Food and Beverage $2,306.67 37

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–53 of 53 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEPHEN J SCHUSTER

NPI 1033147566 · CMS profile ID 138084

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–53 of 53 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1033147566?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEPHEN J SCHUSTER, NPI 1033147566, CMS profile ID 138084. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–53 of 53 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1033147566?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). STEPHEN J SCHUSTER, NPI 1033147566, CMS profile ID 138084. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–53 of 53 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1033147566?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
STEPHEN J SCHUSTER, NPI 1033147566, CMS profile ID 138084, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–53 of 53 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1033147566?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

53 matching records · $49,340.48 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 53 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–53 of 53.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $84.6902/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106043894 CMS
Genmab U.S., Inc. $2,241.0001/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126832321 CMS
BioNTech SE $1,088.0001/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150660488 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $46,347.95 52
PY2020 $49,981.51 18
PY2021 $11,847.00 7
PY2022 $19,916.90 15
PY2023 $17,971.30 27
PY2024 $49,340.48 53
PY2025 $22,704.84 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $8,931.40 6
PY2025 Principal investigator $236,864.98 13
PY2024 Recipient $7,739.58 11
PY2024 Principal investigator $305,092.23 33
PY2023 Recipient $1,113.82 2
PY2023 Principal investigator $405,775.56 27
PY2022 Principal investigator $2,501,857.45 37
PY2021 Recipient $5,039.00 2
PY2021 Principal investigator $1,617,483.86 52
PY2020 Recipient $165.42 1
PY2020 Principal investigator $2,189,816.89 42
PY2019 Recipient $9,773.99 9
PY2019 Principal investigator $1,976,959.99 50

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $5,400.00 12/16/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
CAR T Followed by Bispecific Antibodies No dispute reported 06/30/2026 1211545288
Recipient F. Hoffmann-La Roche AG $964.40 12/12/2025 Covered Recipient Physician Comparative Analysis of outcomes of relapsed/refractory FL patients with at least two prior lines of systemic therapy treated with Monsunetuzumab in study GO29781 with the outcomes of similar patients treated with routinely available treatments in the real world No dispute reported 06/30/2026 1211539055
Recipient F. Hoffmann-La Roche AG $989.42 12/12/2025 Covered Recipient Physician Comparative Analysis of outcomes of relapsed/refractory FL patients with at least two prior lines of systemic therapy treated with Monsunetuzumab in study GO29781 with the outcomes of similar patients treated with routinely available treatments in the real world No dispute reported 06/30/2026 1211539058
Recipient F. Hoffmann-La Roche AG $431.03 12/10/2025 Covered Recipient Physician Comparative Analysis of outcomes of relapsed/refractory FL patients with at least two prior lines of systemic therapy treated with Monsunetuzumab in study GO29781 with the outcomes of similar patients treated with routinely available treatments in the real world No dispute reported 06/30/2026 1211539065
Recipient F. Hoffmann-La Roche AG $431.55 12/08/2025 Covered Recipient Physician Comparative Analysis of outcomes of relapsed/refractory FL patients with at least two prior lines of systemic therapy treated with Monsunetuzumab in study GO29781 with the outcomes of similar patients treated with routinely available treatments in the real world No dispute reported 06/30/2026 1211539061
Principal investigator 1 AstraZeneca Pharmaceuticals LP $36,770.45 11/26/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
A Modular Phase II, Single-arm, Multicenter, Open-label study to evaluate the Efficacy and Safety of AZD0486 in Subjects with Relapsed/Refractory (R/R) B-cell Non-Hodgkin Lymphoma (B-NHL) No dispute reported 06/30/2026 1185552879
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,584.00 11/05/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Expanded Access Protocol (EAP) of subjects receiving nonconforming lisocabtagene maraleucel that is out of specification (OOS) for commercial release No dispute reported 06/30/2026 1236001002
Principal investigator 1 Kite Pharma, Inc. $6,500.00 10/21/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel No dispute reported 06/30/2026 1212067144
Principal investigator 1 Kite Pharma, Inc. $6,500.00 10/14/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel No dispute reported 06/30/2026 1212067158
Recipient Novartis Pharmaceuticals Corporation $115.00 10/09/2025 Covered Recipient Physician Research Publication/ Writing Support No dispute reported 06/30/2026 1190291505
Principal investigator 1 Celgene Corporation $11,925.00 08/20/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No dispute reported 06/30/2026 1222304831
Principal investigator 1 AstraZeneca Pharmaceuticals LP $43,874.45 07/18/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Chronic Lymphocytic Leukemia (CLL) No dispute reported 06/30/2026 1185552881
Principal investigator 1 Genentech, Inc. $14,649.30 06/13/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
AN OPEN-LABEL, MULTICENTER, PHASE I/II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ESCALATING DOSES OF MOSUNETUZUMAB (BTCT4465A) AS A SINGLE AGENT AND COMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKINS LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA No dispute reported 06/30/2026 1211545335
Principal investigator 1 Celgene Corporation $75,756.18 06/12/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
A Phase 2, open-label, single arm, multicohort, multicenter trial to evaluate the efficacy and safety of JCAR017 (lisocabtagene maraleucel) in adult subjects with relapsed or refractory indolent B-cell non-Hodgkin Lymphoma (NHL) No dispute reported 06/30/2026 1222306539
Principal investigator 1 Celgene Corporation $12,690.00 05/05/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Expanded Access Protocol (EAP) of subjects receiving nonconforming lisocabtagene maraleucel that is out of specification (OOS) for commercial release No dispute reported 06/30/2026 1222306447
Principal investigator 1 Janssen Research & Development, LLC $3,150.00 04/17/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
?A Phase 1b Multicenter, Open-label, Study of JNJ-90009530, an Autologous Anti-CD20 CAR-T Cell Therapy in Adult Participants with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma? No dispute reported 06/30/2026 1175342060
Recipient Novartis Pharma AG $6,000.00 02/19/2025 Covered Recipient Physician CCTL019E2202 No dispute reported 06/30/2026 1248109621
Principal investigator 1 Genentech, Inc. $6,177.60 02/05/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
AN OPEN-LABEL, MULTICENTER, PHASE I/II TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ESCALATING DOSES OF MOSUNETUZUMAB (BTCT4465A) AS A SINGLE AGENT AND COMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKINS LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA No dispute reported 06/30/2026 1211545332
Principal investigator 1 Celgene Corporation $8,888.00 01/17/2025 Covered Recipient Teaching Hospital
Hospital Of The Univ Of Penna
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells. A prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. No dispute reported 06/30/2026 1222306411